Correlation Between BioAffinity Technologies, and Aquaron Acquisition
Can any of the company-specific risk be diversified away by investing in both BioAffinity Technologies, and Aquaron Acquisition at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioAffinity Technologies, and Aquaron Acquisition into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between bioAffinity Technologies, and Aquaron Acquisition Corp, you can compare the effects of market volatilities on BioAffinity Technologies, and Aquaron Acquisition and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioAffinity Technologies, with a short position of Aquaron Acquisition. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioAffinity Technologies, and Aquaron Acquisition.
Diversification Opportunities for BioAffinity Technologies, and Aquaron Acquisition
0.45 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between BioAffinity and Aquaron is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding bioAffinity Technologies, and Aquaron Acquisition Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aquaron Acquisition Corp and BioAffinity Technologies, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on bioAffinity Technologies, are associated (or correlated) with Aquaron Acquisition. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aquaron Acquisition Corp has no effect on the direction of BioAffinity Technologies, i.e., BioAffinity Technologies, and Aquaron Acquisition go up and down completely randomly.
Pair Corralation between BioAffinity Technologies, and Aquaron Acquisition
Given the investment horizon of 90 days bioAffinity Technologies, is expected to under-perform the Aquaron Acquisition. In addition to that, BioAffinity Technologies, is 1.04 times more volatile than Aquaron Acquisition Corp. It trades about -0.45 of its total potential returns per unit of risk. Aquaron Acquisition Corp is currently generating about 0.07 per unit of volatility. If you would invest 1,187 in Aquaron Acquisition Corp on October 24, 2024 and sell it today you would earn a total of 40.00 from holding Aquaron Acquisition Corp or generate 3.37% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
bioAffinity Technologies, vs. Aquaron Acquisition Corp
Performance |
| Timeline |
| bioAffinity Technologies, |
| Aquaron Acquisition Corp |
BioAffinity Technologies, and Aquaron Acquisition Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with BioAffinity Technologies, and Aquaron Acquisition
The main advantage of trading using opposite BioAffinity Technologies, and Aquaron Acquisition positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioAffinity Technologies, position performs unexpectedly, Aquaron Acquisition can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aquaron Acquisition will offset losses from the drop in Aquaron Acquisition's long position.| BioAffinity Technologies, vs. Nuvalent | BioAffinity Technologies, vs. Arcellx | BioAffinity Technologies, vs. Vaxcyte | BioAffinity Technologies, vs. Crinetics Pharmaceuticals |
| Aquaron Acquisition vs. Onfolio Holdings | Aquaron Acquisition vs. Horizon Space Acquisition | Aquaron Acquisition vs. bioAffinity Technologies, | Aquaron Acquisition vs. Reborn Coffee |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |